The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
Wakana MurakamiMitsuhiro TozakiSeigo NakamuraYoshimi IdeMayuko InuzukaYuko HirotaKouzou MurakamiNoritsugu TakahamaYoshimitsu OhgiyaTakehiko GokanPublished in: Breast cancer (Tokyo, Japan) (2019)
The imaging and histological characteristics of BRCA1/2 mutation carriers were consistent with other countries' studies. MRI-detected lesions were significantly smaller than lesions detected by non-MRI modality. All lesions in BRCA1 mutation carriers could be detected by MRI.